Erratum: Too much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyond (Genetics in Medicine (2015) DOI: 10.1038/gim.2015.23);Too much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyond

Genetics in Medicine

Volumn 17, Issue 12, 2015, Pages 958-961

  Allyse, Megan ^a   Chandrasekharan, Subhashini ^b  

^a MAYO CLINIC   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

47,XYY SYNDROME; CHROMOSOME ABERRATION; COUNSELING; DIGEORGE SYNDROME; HUMAN; INFORMED CONSENT; KLINEFELTER SYNDROME; MONOSOMY X; NON INVASIVE PROCEDURE; NOTE; PRENATAL SCREENING; SEX CHROMOSOME ABERRATION; TRISOMY; TURNER SYNDROME; VALIDATION STUDY; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME DISORDERS; DOWN SYNDROME; ECONOMICS; ETHICS; FEMALE; MEDICAL ETHICS; PREGNANCY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; UNITED STATES; UTILIZATION;

CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; ETHICS, MEDICAL; FEMALE; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; TRISOMY; UNITED STATES;

EID: 84940689382     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2015.64     Document Type: Erratum

References (36)

1. Karow J. NIPS continues to take off in 2013 as indications, insurance coverage grow. GenomeWeb 2 January2014.
2. United Healthcare. Noninvasive prenatal diagnosis of fetal aneuploidy using cell-free fetal nucleic acids in maternal blood. Policy no. 2014T0560E. https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20 Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20 Policies/Noninvasive-Prenatal-Diagnosis-of-Fetal-Aneuploidy.pdf. Accessed 1 April 2014.
3. Flessel M, Goldman S. California prenatal screening program to include noninvasive testing. ACOG, September 2013. http://www.acog.org/About-ACOG/ACOG-Departments/District-Newsletters/District-IX/September-2013/California-Prenatal-Screening-Program.
4. Driscoll DA. Prenatal diagnosis of the 22q11.2 deletion syndrome. Genet Med 2001;3:14-18.
5. Vora NL, O'Brien BM. Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution. Obstet Gynecol 2014;123:1097-1099.
6. Zimmermann B, Hill M, Gemelos G, et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn 2012;32:1233-1241.
7. Nicolaides KH, Syngelaki A, Gil M, Atanasova V, Atanasova V,Markova D. Validation of targeted sequencing of single-nucleotide polymorphisms for noninvasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat Diagn 2013;33:575-579.
8. Norton ME, Brar H, Weiss J, et al. Non-invasive chromosomal evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137.e1-137.e8.
9. Porreco RP, Garite TJ, Maurel K, et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol 2014;211:365.e1-365.e12.
10. Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014;370:799-808.
11. Pergament E, Cuckle H, Zimmermann B, et al. Single-nucleotide polymorphismbased noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet Gynecol 2014;124(2 Pt 1):210-218.
12. Srinivasan A, Bianchi DW, Huang H, Sehnert AJ, Rava RP. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 2013;92:167-176.
13. Rabinowitz M, Savage M, Pettersen B, Sigurjonsson S, Hill M, Zimmermann B. Noninvasive cell-free DNA-based prenatal detection of microdeletions using single nucleotide polymorphism-targeted sequencing. Obstet Gynecol 2014;123(suppl 1):167S.
14. Dharajiya N, Monroe T, Boomer T, Jenna W, Jesiolowski J, Salvidar J. NIPS 2.0: identification of 22q microdeletions by non-invasive prenatal testing. Prenat Diagn 2014;34(suppl 1):1-21.
15. Mazloom AR, Džakula Ž, Oeth P, et al. Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat Diagn 2013;33:591-597.
16. Samango-Sprouse C, Banjevic M, Ryan A, et al. SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy. Prenat Diagn 2013;33:643-649.
17. Sheets KB, Crissman BG, Feist CD, et al. Practice guidelines for communicating a prenatal or postnatal diagnosis of Down syndrome: recommendations of the national society of genetic counselors. J Genet Couns 2011;20:432-441.
18. Kellogg G, Slattery L, Hudgins L, Ormond K. Attitudes of mothers of children with down syndrome towards noninvasive prenatal testing. J Genet Couns 2014;23:805-813.
19. Down Syndrome Diagnosis Study Group; Skotko BG, Kishnani PS, Capone GT. Prenatal diagnosis of Down syndrome: how best to deliver the news. Am J Med Genet A 2009;149A:2361-2367.
20. Hall S, Abramsky L, Marteau TM. Health professionals' reports of information given to parents following the prenatal diagnosis of sex chromosome anomalies and outcomes of pregnancies: a pilot study. Prenat Diagn 2003;23:535-538.
21. Abramsky L, Hall S, Levitan J, Marteau TM. What parents are told after prenatal diagnosis of a sex chromosome abnormality: interview and questionnaire study. BMJ 2001;322:463-466.
22. Tartaglia N, Ayari N, Howell S, D'Epagnier C, Zeitler P. 48,XXYY, 48,XXXY and 49,XXXXY syndromes: not just variants of Klinefelter syndrome. Acta Paediatr 2011;100:851-860.
23. Herlihy AS, Halliday J, McLachlan RI, Cock M, Gillam L. Assessing the risks and benefits of diagnosing genetic conditions with variable phenotypes through population screening: Klinefelter syndrome as an example. J Community Genet 2010;1:41-46.
24. Visootsak J, Ayari N, Howell S, Lazarus J, Tartaglia N. Timing of diagnosis of 47,XXY and 48,XXYY: a survey of parent experiences. Am J Med Genet A 2013;161A:268-272.
25. Bardsley MZ, Kowal K, Levy C, et al. 47,XYY syndrome: clinical phenotype and timing of ascertainment. J Pediatr 2013;163:1085-1094.
26. Wang Y, Chen Y, Tian F, et al. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem 2014;60:251-259.
27. Norton ME, Rose NC, Benn P. Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint. Obstet Gynecol 2013;121:847-850.
28. Bensend TA, Veach PM, Niendorf KB. What's the harm Genetic counselor perceptions of adverse effects of genetics service provision by non-genetics professionals. J Genet Couns 2014;23:48-63.
29. Pollack A. Conflict potential seen in genetic counselors. New York Times 13 July2012.
30. Swanson A, Ramos E, Snyder H. Next generation sequencing is the impetus for the next generation of laboratory-based genetic counselors. J Genet Couns 2014;23:647-654.
31. Benn P, Chapman AR, Erickson K, et al. Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testing. Prenat Diagn 2014;34:145-152.
32. Ehrich M, Deciu C, Zhao CZ, et al. Genome wide analysis of sub chromosomal copy number variations using NIPS in <4500 patients (Abstract). Prenat Diagn 2014;34(suppl 1):10-11.
33. Bennett R. Antenatal genetic testing and the right to remain in ignorance. Theor Med Bioeth 2001;22:461-471.
34. Dickens BM. Ethical and legal aspects of noninvasive prenatal genetic diagnosis. Int J Gynaecol Obstet 2014;124:181-184.
35. Hassan M, Chitty L, Reardon H. Wrongful birth: clinical settings and legal implications. Semin Fetal Neonatal Med 2014;19:312-316.
36. Agarwal A, Sayres LC, Cho MK, Cook-Deegan R, Chandrasekharan S. Commercial landscape of noninvasive prenatal testing in the United States. Prenat Diagn 2013;33:521-531.